BioSpace News Archive

Rising Prevalence of Lysosomal Storage Disorders Across the Globe is Expected to Drive Pompe Disease Treatment Market Growth by 2030 | Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Pompe Disease Treatment Market – Forecast to 2030,’ thoroughly examines the Pompe Disease Treatment industry to provide essential data & information for the targeted readers.

September 28, 2022
·
6 min read
BioCapital

careviso Raises Over $17 million in Series B Funding to Enhance Transparency and Access for Diagnostic Testing

careviso, a healthcare technology company and market leader in molecular diagnostic patient access technology (the “Company”), today announced that it has raised over $17 million in Series B funding led by Ballast Point Ventures with participation from existing investors Mercury and Lytical Ventures.

September 28, 2022
·
4 min read
Business

NOTA Laboratories Signs Joint Development Agreement With NGK Sparkplugs

NOTA Laboratories, a development stage company focused on proprietary nitric oxide (NO) delivery systems to treat a wide variety of acute and chronic respiratory and inflammatory illnesses, has just signed a Joint Development Agreement with NGK Spark Plugs of Nagoya, Japan.

September 28, 2022
·
2 min read
Board of Directors Approves Half-Year Financial Report as of June 30, 2022

The Board of Directors of Philogen S.p.A. and, together with its Swiss subsidiary Philochem, which met under the chairmanship of Dr. Duccio Neri, approved the condensed consolidated half-yearly financial statements as of June 30, 2022, prepared in accordance with IAS/IFRS.

September 28, 2022
·
19 min read
Biotech Bay

STATEMENT ON GOVERNOR’S VETO OF DIAGNOSTIC IMAGING LEGISLATION IN CALIFORNIA

Susan G. Komen®, the world’s leading breast cancer organization, today issued the following statement on the veto of diagnostic imaging legislation (SB 974) by Governor Gavin Newsom.

September 28, 2022
·
2 min read
Biotech Bay

Gladstone Institutes Joins the Parker Institute for Cancer Immunotherapy Network

Gladstone Institutes has partnered with the Parker Institute for Cancer Immunotherapy, the leading network of immuno-oncology expertise in the world, to establish a new research center focused on using genomics and CRISPR technology to program the human immune system to treat cancer.

September 28, 2022
·
4 min read
Mainstay Medical Announces Publication of Three-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™

Mainstay Medical Holdings plc today announced the publication of the three-year patient outcomes data from its pivotal ReActiv8-B clinical trial.

September 28, 2022
·
5 min read
FDA

Press Release: Dupixent® (dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis

The U.S. Food and Drug Administration has approved Dupixent® for the treatment of adult patients with prurigo nodularis.

September 28, 2022
·
17 min read
Sirona Biochem Issues Corporate Update - September 29, 2022

Sirona Biochem Corp. announces the release of a corporate update which highlights the company’s recent team meeting in France, the current pipeline, and the latest deal structure.

September 28, 2022
·
2 min read
Genetown

Molecular Loop Biosciences launches Monkeypox Research Sequencing Panels

Molecular Loop Biosciences, Inc., announced today that it has launched monkeypox targeting panels to support researchers conducting monkeypox viral surveillance and variant discovery.

September 28, 2022
·
2 min read